CelerX Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

CelerX General Information


Developer of a prophylactic treatment designed to treat coeliac disease. The company's treatment a prophylactic microbiome-based product that provides constitutive protection against the problem of accidental gluten contamination, enabling patients to ensure the avoidance of symptoms from gluten contamination.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • Cambridge
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CelerX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view CelerX’s complete valuation and funding history, request access »

CelerX Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelerate Cambridge Accelerator/Incubator 000 0000 000000 0
To view CelerX’s complete investors history, request access »